KARAMBIOSCIENCE
EST. 2026
EVIDENCE / 02
A cinematic molecular-and-climate scene with a CRISPR complex, cells and a planet.
CRISPR Atlas / External evidence
Human cell models

GNPTAB–STING: separate harmful signaling from maintenance

A focused Cas9 screen identified GNPTAB as a regulator of senescence. The assessment describes a noncanonical interaction with STING and a binding-deficient mutant that retained the tested lysosomal functions without inducing senescence.

Concept illustration / not experimental evidence

What was reported

A focused Cas9 screen identified GNPTAB as a regulator of senescence. The assessment describes a noncanonical interaction with STING and a binding-deficient mutant that retained the tested lysosomal functions without inducing senescence. [C01]

What the result does not establish

This is mechanistic human-cell evidence, not treatment of people. Deleting or suppressing GNPTAB everywhere would not follow from an interaction-specific result.

Measured endpoint

Senescence-associated behavior; inflammatory signaling; tested lysosomal functions.

Karam’s next question

Can the unwanted interaction be interrupted while preserving essential maintenance, and does the benefit replicate independently?

Assessment-derived brief. Cited in the supplied 15 October 2026 project assessment; not independently reviewed in this website release. Karam has not reproduced the experiment or independently audited the underlying dataset. This is not Karam-generated evidence.

Record transparency

The details—and the missing values.

Extraction scope: supplied project assessment, not an independent full-methods extraction
Study date2026-07-27
Reported regionChina
Species / biological systemHuman
Target / subjectGNPTAB / STING
Cell or population contextHuman mesenchymal progenitor cells
Perturbation directionDisruption; overexpression; interaction separation
MethodCas9 screen
Delivery settingCell-based perturbations
ComparatorNot extracted in the supplied assessment; review the primary source before using this field.
Donor contextNot extracted in the supplied assessment; review the primary source before using this field.
Sample size / unitNot extracted in the supplied assessment; review the primary source before using this field.
Follow-upNot extracted in the supplied assessment; review the primary source before using this field.
Safety measurementsPreservation of tested canonical lysosomal functions was described; wider safety remains unresolved.
Independent replicationNot established in the supplied assessment
Data accessNot extracted in the supplied assessment; review the primary source before using this field.

What would this evidence change?

Use the context in this record to define a bounded research or diligence question. A cited finding is not a validated Karam asset.